Expression of programmed cell death-ligand 1 and associated lymphocyte infiltration in olfactory neuroblastoma.
Programmed death-ligand 1 (PD-L1) is a transmembrane glycoprotein which interacts with the receptor programmed death 1 (PD-1) to suppress T cell activation, reduce adjacent tissue damage, and promote tolerance to self-antigens. Tumors may express PD-L1 as a mechanism to evade immune detection. Recent clinical trials have demonstrated the efficacy of PD-L1/PD-1 antagonists through activation of tumor infiltrated CD8+ T cells. To determine the expression pattern of PD-L1 and PD-1 in olfactory neuroblastoma (ONB) tumor cells, and to determine the presence of PD-1+ and CD8+ lymphocytes in the ONB immune microenvironment. Immunohistochemistry for the expression of PD-L1, PD-1, and CD8 was performed on paraffin embedded ONB tissue. Of the ten primary site ONB samples, four demonstrated positive PD-L1 expression. Of PD-L1+ tumors, the two highest expressing samples were found to contain PD-1+ tumor cells. Of the four available metastatic samples arising from PD-L1 negative primary site ONB, three were positive for PD-L1 of which all were found to contain PD-1+ tumor cells. PD-L1+ primary and metastatic tumors also demonstrated increased PD-1+ infiltrating lymphocytes in the tumor and stroma (11.6 and 4.62 fold increase) compared to PD-L1 negative samples (P<0.05 and P=0.068 respectively). PD-L1+ specimens demonstrated increased CD8+ lymphocytes in the tumor and stroma (7.46 and 2.14 fold increase) compared to PD-L1 negative tumors (P<0.05 for both). These data demonstrate that a proportion of ONB primary and metastatic tumors express PD-L1 and possess an associated tumor and stromal infiltrate of PD-1+ and CD8+ lymphocytes.